SHOWALTER HOWARD DANIEL HOLLIS

No ORCID on file · 108 papers in corpus
2008

The invention relates to compounds represented by formula I: which are irreversible inhibitors of tyrosine kinazes, to pharmaceutiyal compositions containing the same and to the use thereof in the treatment of cancer, atherosclerosis, reste…

2008

The invention relates to compounds represented by formula I: which are irreversible inhibitors of tyrosine kinazes, to pharmaceutiyal compositions containing the same and to the use thereof in the treatment of cancer, atherosclerosis, reste…

2008

The invention relates to compounds represented by formula I: which are irreversible inhibitors of tyrosine kinazes, to pharmaceutiyal compositions containing the same and to the use thereof in the treatment of cancer, atherosclerosis, reste…

2008

The invention relates to compounds represented by formula I: which are irreversible inhibitors of tyrosine kinazes, to pharmaceutiyal compositions containing the same and to the use thereof in the treatment of cancer, atherosclerosis, reste…

2008

The invention relates to compounds represented by formula I: which are irreversible inhibitors of tyrosine kinazes, to pharmaceutiyal compositions containing the same and to the use thereof in the treatment of cancer, atherosclerosis, reste…

2008

The invention relates to compounds represented by formula I: which are irreversible inhibitors of tyrosine kinazes, to pharmaceutiyal compositions containing the same and to the use thereof in the treatment of cancer, atherosclerosis, reste…

2008

The invention relates to compounds represented by formula I: which are irreversible inhibitors of tyrosine kinazes, to pharmaceutiyal compositions containing the same and to the use thereof in the treatment of cancer, atherosclerosis, reste…

2008

The invention relates to compounds represented by formula I: which are irreversible inhibitors of tyrosine kinazes, to pharmaceutiyal compositions containing the same and to the use thereof in the treatment of cancer, atherosclerosis, reste…

2008

The invention relates to compounds represented by formula I: which are irreversible inhibitors of tyrosine kinazes, to pharmaceutiyal compositions containing the same and to the use thereof in the treatment of cancer, atherosclerosis, reste…

2008

The invention relates to compounds represented by formula I: which are irreversible inhibitors of tyrosine kinazes, to pharmaceutiyal compositions containing the same and to the use thereof in the treatment of cancer, atherosclerosis, reste…

2008

The invention relates to compounds represented by formula I: which are irreversible inhibitors of tyrosine kinazes, to pharmaceutiyal compositions containing the same and to the use thereof in the treatment of cancer, atherosclerosis, reste…

2008

The invention relates to compounds represented by formula I: which are irreversible inhibitors of tyrosine kinazes, to pharmaceutiyal compositions containing the same and to the use thereof in the treatment of cancer, atherosclerosis, reste…

2008

The invention relates to compounds represented by formula I: which are irreversible inhibitors of tyrosine kinazes, to pharmaceutiyal compositions containing the same and to the use thereof in the treatment of cancer, atherosclerosis, reste…

2008

The invention relates to compounds represented by formula I: which are irreversible inhibitors of tyrosine kinazes, to pharmaceutiyal compositions containing the same and to the use thereof in the treatment of cancer, atherosclerosis, reste…

2008

The invention relates to compounds represented by formula I: which are irreversible inhibitors of tyrosine kinazes, to pharmaceutiyal compositions containing the same and to the use thereof in the treatment of cancer, atherosclerosis, reste…

2008

The invention relates to compounds represented by formula I: which are irreversible inhibitors of tyrosine kinazes, to pharmaceutiyal compositions containing the same and to the use thereof in the treatment of cancer, atherosclerosis, reste…

2008

The invention relates to compounds represented by formula I: which are irreversible inhibitors of tyrosine kinazes, to pharmaceutiyal compositions containing the same and to the use thereof in the treatment of cancer, atherosclerosis, reste…

2008

The invention relates to compounds represented by formula I: which are irreversible inhibitors of tyrosine kinazes, to pharmaceutiyal compositions containing the same and to the use thereof in the treatment of cancer, atherosclerosis, reste…

2008

The invention relates to compounds represented by formula I: which are irreversible inhibitors of tyrosine kinazes, to pharmaceutiyal compositions containing the same and to the use thereof in the treatment of cancer, atherosclerosis, reste…

2008

The invention relates to compounds represented by formula I: which are irreversible inhibitors of tyrosine kinazes, to pharmaceutiyal compositions containing the same and to the use thereof in the treatment of cancer, atherosclerosis, reste…

2008

The invention relates to compounds represented by formula I: which are irreversible inhibitors of tyrosine kinazes, to pharmaceutiyal compositions containing the same and to the use thereof in the treatment of cancer, atherosclerosis, reste…

2008

The invention relates to compounds represented by formula I: which are irreversible inhibitors of tyrosine kinazes, to pharmaceutiyal compositions containing the same and to the use thereof in the treatment of cancer, atherosclerosis, reste…

2008

The invention relates to compounds represented by formula I: which are irreversible inhibitors of tyrosine kinazes, to pharmaceutiyal compositions containing the same and to the use thereof in the treatment of cancer, atherosclerosis, reste…

2008

The invention relates to compounds represented by formula I: which are irreversible inhibitors of tyrosine kinazes, to pharmaceutiyal compositions containing the same and to the use thereof in the treatment of cancer, atherosclerosis, reste…

2008

The invention relates to compounds represented by formula I: which are irreversible inhibitors of tyrosine kinazes, to pharmaceutiyal compositions containing the same and to the use thereof in the treatment of cancer, atherosclerosis, reste…